abstract |
A compound of formula (I) or a pharmaceutically acceptable salt thereof: (I) In the formula (I) A, X, R 1 , R 2 , R 3 and R 4 are as defined herein. In addition, the present invention discloses methods and uses for the preparation of compounds for the treatment of diseases associated with LRRK2 receptors, such as Parkinson's disease. |